brimonidine tartrate

Modality

—

Mechanism

12.1 Mechanism of Action Brimonidine is a relatively selective alpha-2 adrenergic agonist. Topical application of MIRVASO topical gel may reduce erythema through direct vasoconstriction.

Targets

—

Storage

—

Approved

rosacea — FDA

In trial

rosacea

Sources

DailyMed (FDA label)ClinicalTrials.gov

Last verified

2026-04-23

No curated MOA diagram yet. See lib/moa-data.ts for the shape; add an entry keyed by brimonidine tartrate.

Formulations

0.33% gel